Pnc Financial Services Group, Inc. Igm Biosciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 23 shares of IGMS stock, worth $204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 23
-0.0%
Holding current value
$204
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IGMS
# of Institutions
81Shares Held
20.7MCall Options Held
68KPut Options Held
52.2K-
Baker Bros. Advisors LP New York, NY4.09MShares$36.4 Million0.72% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.01MShares$35.7 Million0.01% of portfolio
-
Siren, L.L.C. New York, NY3.33MShares$29.6 Million2.75% of portfolio
-
Redmile Group, LLC San Francisco, CA3.07MShares$27.3 Million3.32% of portfolio
-
Goldman Sachs Group Inc New York, NY1.26MShares$11.2 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $258M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...